Effects of the α2-adrenergic receptor agonist dexmedetomidine on neural, vascular and BOLD fMRI responses in the somatosensory cortex

European Journal of Neuroscience

Volumn 37, Issue 1, 2013, Pages 80-95

  Fukuda, Mitsuhiro ^a   Vazquez, Alberto L ^a   Zong, Xiaopeng ^a   Kim, Seong Gi ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Blood oxygenation level dependent; Cerebral blood volume; Functional connectivity; Medetomidine; Rat

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR; DEXMEDETOMIDINE; ISOFLURANE; NITROUS OXIDE;

ANESTHESIA MECHANISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY DIAMETER; ARTERY DILATATION; ARTICLE; BETA RHYTHM; BOLD SIGNAL; BRAIN BLOOD FLOW; BRAIN BLOOD VOLUME; CELL ACTIVITY; CONTINUOUS INFUSION; CONTROLLED STUDY; DELTA RHYTHM; ELECTRICAL POTENTIAL PARAMETERS; EPILEPSY; EVOKED SOMATOSENSORY RESPONSE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GAMMA RHYTHM; LOCAL FIELD POTENTIAL; MALE; NERVE CELL MEMBRANE POTENTIAL; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; SEDATION; SOMATOSENSORY CORTEX; SOMATOSENSORY STIMULATION; SPIKE; VEIN DIAMETER; VEIN DILATATION; VENOCONSTRICTION;

ADRENERGIC ALPHA-2 RECEPTOR AGONISTS; ANESTHETICS, INHALATION; ANIMALS; BRAIN WAVES; CEREBRAL ARTERIES; CEREBRAL VEINS; DEXMEDETOMIDINE; EPILEPSY; HINDLIMB; ISOFLURANE; MAGNETIC RESONANCE IMAGING; MALE; NITRIC OXIDE; OXYGEN; RATS; RATS, SPRAGUE-DAWLEY; SOMATOSENSORY CORTEX; VASOCONSTRICTION; VASODILATION;

EID: 84872142105     PISSN: 0953816X     EISSN: 14609568     Source Type: Journal    
DOI: 10.1111/ejn.12024     Document Type: Article

References (99)

1. Airaksinen, A.M., Niskanen, J.P., Chamberlain, R., Huttunen, J.K., Nissinen, J., Garwood, M., Pitkanen, A. & Grohn, O. (2010) Simultaneous fMRI and local field potential measurements during epileptic seizures in medetomidine-sedated rats using raser pulse sequence. Magn. Reson. Med., 64, 1191-1199.
2. Angenstein, F., Krautwald, K. & Scheich, H. (2010) The current functional state of local neuronal circuits controls the magnitude of a BOLD response to incoming stimuli. Neuroimage, 50, 1364-1375.
3. Ansah, O.B., Raekallio, M. & Vainio, O. (2000) Correlation between serum concentrations following continuous intravenous infusion of dexmedetomidine or medetomidine in cats and their sedative and analgesic effects. J. Vet. Pharmacol. Ther., 23, 1-8.
4. Asano, Y., Koehler, R.C., Kawaguchi, T. & McPherson, R.W. (1997) Pial arteriolar constriction to alpha 2-adrenergic agonist dexmedetomidine in the rat. Am. J. Physiol., 272, H2547-H2556.
5. Banoub, M., Tetzlaff, J.E. & Schubert, A. (2003) Pharmacologic and physiologic influences affecting sensory evoked potentials: implications for perioperative monitoring. Anesthesiology, 99, 716-737.
6. Bari, F., Horvath, G. & Benedek, G. (1993) Dexmedetomidine-induced decrease in cerebral blood flow is attenuated by verapamil in rats: a laser Doppler study. Can. J. Anaesth., 40, 748-754.
7. Bekar, L.K., He, W. & Nedergaard, M. (2008) Locus coeruleus alpha-adrenergic-mediated activation of cortical astrocytes in vivo. Cereb. Cortex, 18, 2789-2795.
8. Bekker, A. & Sturaitis, M.K. (2005) Dexmedetomidine for neurological surgery. Neurosurgery, 57, 1-10; discussion 11-10.
9. Berwick, J., Martin, C., Martindale, J., Jones, M., Johnston, D., Zheng, Y., Redgrave, P. & Mayhew, J. (2002) Hemodynamic response in the unanesthetized rat: intrinsic optical imaging and spectroscopy of the barrel cortex. J. Cereb. Blood Flow Metab., 22, 670-679.
10. Bol, C., Danhof, M., Stanski, D.R. & Mandema, J.W. (1997) Pharmacokinetic-pharmacodynamic characterization of the cardiovascular, hypnotic, EEG and ventilatory responses to dexmedetomidine in the rat. J. Pharmacol. Exp. Ther., 283, 1051-1058.
11. Bol, C.J., Vogelaar, J.P. & Mandema, J.W. (1999) Anesthetic profile of dexmedetomidine identified by stimulus-response and continuous measurements in rats. J. Pharmacol. Exp. Ther., 291, 153-160.
12. Buxton, R.B., Wong, E.C. & Frank, L.R. (1998) Dynamics of blood flow and oxygenation changes during brain activation: the balloon model. Magn. Reson. Med., 39, 855-864.
13. Campagna, J.A., Miller, K.W. & Forman, S.A. (2003) Mechanisms of actions of inhaled anesthetics. N. Engl. J. Med., 348, 2110-2124.
14. Chen, Y., Zhao, Z., Code, W.E. & Hertz, L. (2000) A correlation between dexmedetomidine-induced biphasic increases in free cytosolic calcium concentration and energy metabolism in astrocytes. Anesth. Analg., 91, 353-357.
15. Cohen, Z., Molinatti, G. & Hamel, E. (1997) Astroglial and vascular interactions of noradrenaline terminals in the rat cerebral cortex. J. Cereb. Blood Flow Metab., 17, 894-904.
16. Constantinople, C.M. & Bruno, R.M. (2011) Effects and mechanisms of wakefulness on local cortical networks. Neuron, 69, 1061-1068.
17. Correa-Sales, C., Rabin, B.C. & Maze, M. (1992) A hypnotic response to dexmedetomidine, an alpha 2 agonist, is mediated in the locus coeruleus in rats. Anesthesiology, 76, 948-952.
18. DiTullio, N.W., Cieslinski, L., Matthews, W.D. & Storer, B. (1984) Mechanisms involved in the hyperglycemic response induced by clonidine and other alpha-2 adrenoceptor agonists. J. Pharmacol. Exp. Ther., 228, 168-173.
19. Doze, V.A., Chen, B.X. & Maze, M. (1989) Dexmedetomidine produces a hypnotic-anesthetic action in rats via activation of central alpha-2 adrenoceptors. Anesthesiology, 71, 75-79.
20. Drew, P.J., Shih, A.Y. & Kleinfeld, D. (2011) Fluctuating and sensory-induced vasodynamics in rodent cortex extend arteriole capacity. Proc. Natl. Acad. Sci. USA, 108, 8473-8478.
21. Fale, A., Kirsch, J.R. & McPherson, R.W. (1994) Alpha 2-adrenergic agonist effects on normocapnic and hypercapnic cerebral blood flow in the dog are anesthetic dependent. Anesth. Analg., 79, 892-898.
22. Farber, N.E., Poterack, K.A. & Schmeling, W.T. (1997) Dexmedetomidine and halothane produce similar alterations in electroencephalographic and electromyographic activity in cats. Brain Res., 774, 131-141.
23. Ganjoo, P., Farber, N.E., Hudetz, A., Smith, J.J., Samso, E., Kampine, J.P. & Schmeling, W.T. (1998) In vivo effects of dexmedetomidine on laser-Doppler flow and pial arteriolar diameter. Anesthesiology, 88, 429-439.
24. Gsell, W., Burke, M., Wiedermann, D., Bonvento, G., Silva, A.C., Dauphin, F., Buhrle, C., Hoehn, M. & Schwindt, W. (2006) Differential effects of NMDA and AMPA glutamate receptors on functional magnetic resonance imaging signals and evoked neuronal activity during forepaw stimulation of the rat. J. Neurosci., 26, 8409-8416.
25. Guo, T.Z., Jiang, J.Y., Buttermann, A.E. & Maze, M. (1996) Dexmedetomidine injection into the locus ceruleus produces antinociception. Anesthesiology, 84, 873-881.
26. Hartman, B.K., Zide, D. & Udenfriend, S. (1972) The use of dopamine-hydroxylase as a marker for the central noradrenergic nervous system in rat brain. Proc. Natl. Acad. Sci. USA, 69, 2722-2726.
27. Hayashi, Y., Guo, T.Z. & Maze, M. (1995) Desensitization to the behavioral effects of alpha 2-adrenergic agonists in rats. Anesthesiology, 82, 954-962.
28. Hikasa, Y., Kawanabe, H., Takase, K. & Ogasawara, S. (1996) Comparisons of sevoflurane, isoflurane, and halothane anesthesia in spontaneously breathing cats. Vet. Surg., 25, 234-243.
29. Hillman, E.M., Devor, A., Bouchard, M.B., Dunn, A.K., Krauss, G.W., Skoch, J., Bacskai, B.J., Dale, A.M. & Boas, D.A. (2007) Depth-resolved optical imaging and microscopy of vascular compartment dynamics during somatosensory stimulation. Neuroimage, 35, 89-104.
30. + channel activation. Anesthesiology, 89, 954-960.
31. Iida, H., Iida, M., Ohata, H., Michino, T. & Dohi, S. (2006) Effects of dexmedetomidine on cerebral circulation and systemic hemodynamics after cardiopulmonary resuscitation in dogs. J. Anesth., 20, 202-207.
32. Ishiyama, T., Dohi, S., Iida, H., Watanabe, Y. & Shimonaka, H. (1995) Mechanisms of dexmedetomidine-induced cerebrovascular effects in canine in vivo experiments. Anesth. Analg., 81, 1208-1215.
33. Jensen, F.E., Applegate, C.D., Holtzman, D., Belin, T.R. & Burchfiel, J.L. (1991) Epileptogenic effect of hypoxia in the immature rodent brain. Ann. Neurol., 29, 629-637.
34. Jevtovic-Todorovic, V., Todorovic, S.M., Mennerick, S., Powell, S., Dikranian, K., Benshoff, N., Zorumski, C.F. & Olney, J.W. (1998) Nitrous oxide (laughing gas) is an NMDA antagonist, neuroprotectant and neurotoxin. Nat. Med., 4, 460-463.
35. Kalso, E.A., Poyhia, R. & Rosenberg, P.H. (1991) Spinal antinociception by dexmedetomidine, a highly selective alpha 2-adrenergic agonist. Pharmacol. Toxicol., 68, 140-143.
36. Kalthoff, D., Seehafer, J.U., Po, C., Wiedermann, D. & Hoehn, M. (2011) Functional connectivity in the rat at 11.7T: impact of physiological noise in resting state fMRI. Neuroimage, 54, 2828-2839.
37. Kamibayashi, T. & Maze, M. (2000) Clinical uses of alpha2-adrenergic agonists. Anesthesiology, 93, 1345-1349.
38. Karlsson, B.R., Forsman, M., Roald, O.K., Heier, M.S. & Steen, P.A. (1990) Effect of dexmedetomidine, a selective and potent alpha 2-agonist, on cerebral blood flow and oxygen consumption during halothane anesthesia in dogs. Anesth. Analg., 71, 125-129.
39. Kawano, T., Tanaka, K., Mawatari, K., Oshita, S., Takahashi, A. & Nakaya, Y. (2008) Hyperglycemia impairs isoflurane-induced adenosine triphosphate-sensitive potassium channel activation in vascular smooth muscle cells. Anesth. Analg., 106, 858-864.
40. Kim, T., Hendrich, K.S., Masamoto, K. & Kim, S.G. (2007) Arterial versus total blood volume changes during neural activity-induced cerebral blood flow change: implication for BOLD fMRI. J. Cereb. Blood Flow Metab., 27, 1235-1247.
41. Kim, T., Masamoto, K., Fukuda, M., Vazquez, A. & Kim, S.G. (2010) Frequency-dependent neural activity, CBF, and BOLD fMRI to somatosensory stimuli in isoflurane-anesthetized rats. Neuroimage, 52, 224-233.
42. Krautwald, K. & Angenstein, F. (2012) Low frequency stimulation of the perforant pathway generates anesthesia-specific variations in neural activity and BOLD responses in the rat dentate gyrus. J. Cereb. Blood Flow Metab., 32, 291-305.
43. Li, B.H., Lohmann, J.S., Schuler, H.G. & Cronin, A.J. (2003) Preservation of the cortical somatosensory-evoked potential during dexmedetomidine infusion in rats. Anesth. Analg., 96, 1155-1160.
44. Lu, H., Zou, Q., Gu, H., Raichle, M.E., Stein, E.A. & Yang, Y. (2012) Rat brains also have a default mode network. Proc. Natl. Acad. Sci. USA, 109, 3979-3984.
45. MacDonald, E., Scheinin, M., Scheinin, H. & Virtanen, R. (1991) Comparison of the behavioral and neurochemical effects of the two optical enantiomers of medetomidine, a selective alpha-2-adrenoceptor agonist. J. Pharmacol. Exp. Ther., 259, 848-854.
46. Mandeville, J.B., Marota, J.J., Kosofsky, B.E., Keltner, J.R., Weissleder, R., Rosen, B.R. & Weisskoff, R.M. (1998) Dynamic functional imaging of relative cerebral blood volume during rat forepaw stimulation. Magn. Reson. Med., 39, 615-624.
47. Mandeville, J.B., Marota, J.J., Ayata, C., Zaharchuk, G., Moskowitz, M.A., Rosen, B.R. & Weisskoff, R.M. (1999) Evidence of a cerebrovascular postarteriole windkessel with delayed compliance. J. Cereb. Blood Flow Metab., 19, 679-689.
48. Martin, C., Martindale, J., Berwick, J. & Mayhew, J. (2006) Investigating neural-hemodynamic coupling and the hemodynamic response function in the awake rat. Neuroimage, 32, 33-48.
49. Masamoto, K., Kim, T., Fukuda, M., Wang, P. & Kim, S.G. (2007) Relationship between neural, vascular, and BOLD signals in isoflurane-anesthetized rat somatosensory cortex. Cereb. Cortex, 17, 942-950.
50. Masamoto, K., Fukuda, M., Vazquez, A. & Kim, S.G. (2009) Dose-dependent effect of isoflurane on neurovascular coupling in rat cerebral cortex. Eur. J. Neurosci., 30, 242-250.
51. McPherson, R.W., Kirsch, J.R. & Traystman, R.J. (1994) Inhibition of nitric oxide synthase does not affect alpha 2-adrenergic-mediated cerebral vasoconstriction. Anesth. Analg., 78, 67-72.
52. Mennerick, S., Jevtovic-Todorovic, V., Todorovic, S.M., Shen, W., Olney, J.W. & Zorumski, C.F. (1998) Effect of nitrous oxide on excitatory and inhibitory synaptic transmission in hippocampal cultures. J. Neurosci., 18, 9716-9726.
53. Mirski, M.A., Rossell, L.A., McPherson, R.W. & Traystman, R.J. (1994) Dexmedetomidine decreases seizure threshold in a rat model of experimental generalized epilepsy. Anesthesiology, 81, 1422-1428.
54. Miyazaki, Y., Adachi, T., Kurata, J., Utsumi, J., Shichino, T. & Segawa, H. (1999) Dexmedetomidine reduces seizure threshold during enflurane anaesthesia in cats. Br. J. Anaesth., 82, 935-937.
55. Morgan, N.G. & Montague, W. (1985) Studies on the mechanism of inhibition of glucose-stimulated insulin secretion by noradrenaline in rat islets of Langerhans. Biochem. J., 226, 571-576.
56. Nakadate, T., Nakaki, T., Muraki, T. & Kato, R. (1980) Adrenergic regulation of blood glucose levels: possible involvement of postsynaptic alpha-2 type adrenergic receptors regulating insulin release. J. Pharmacol. Exp. Ther., 215, 226-230.
57. Nakai, K., Itakura, T., Naka, Y., Nakakita, K., Kamei, I., Imai, H., Yokote, H. & Komai, N. (1986) The distribution of adrenergic receptors in cerebral blood vessels: an autoradiographic study. Brain Res., 381, 148-152.
58. Nasrallah, F.A., Tan, J. & Chuang, K.H. (2012) Pharmacological modulation of functional connectivity: alpha2-adrenergic receptor agonist alters synchrony but not neural activation. Neuroimage, 60, 436-446.
59. Norup Nielsen, A. & Lauritzen, M. (2001) Coupling and uncoupling of activity-dependent increases of neuronal activity and blood flow in rat somatosensory cortex. J. Physiol., 533, 773-785.
60. Ohata, H., Iida, H., Dohi, S. & Watanabe, Y. (1999) Intravenous dexmedetomidine inhibits cerebrovascular dilation induced by isoflurane and sevoflurane in dogs. Anesth. Analg., 89, 370-377.
61. Oishi, R. & Suenaga, N. (1982) The role of the locus coeruleus in regulation of seizure susceptibility in rats. Jpn. J. Pharmacol., 32, 1075-1081.
62. Paspalas, C.D. & Papadopoulos, G.C. (1996) Ultrastructural relationships between noradrenergic nerve fibers and non-neuronal elements in the rat cerebral cortex. Glia, 17, 133-146.
63. Pawela, C.P., Biswal, B.B., Cho, Y.R., Kao, D.S., Li, R., Jones, S.R., Schulte, M.L., Matloub, H.S., Hudetz, A.G. & Hyde, J.S. (2008) Resting-state functional connectivity of the rat brain. Magn. Reson. Med., 59, 1021-1029.
64. Pawela, C.P., Biswal, B.B., Hudetz, A.G., Schulte, M.L., Li, R., Jones, S.R., Cho, Y.R., Matloub, H.S. & Hyde, J.S. (2009) A protocol for use of medetomidine anesthesia in rats for extended studies using task-induced BOLD contrast and resting-state functional connectivity. Neuroimage, 46, 1137-1147.
65. Pertovaara, A., Kauppila, T., Jyvasjarvi, E. & Kalso, E. (1991) Involvement of supraspinal and spinal segmental alpha-2-adrenergic mechanisms in the medetomidine-induced antinociception. Neuroscience, 44, 705-714.
66. Pertovaara, A., Hamalainen, M.M., Kauppila, T., Mecke, E. & Carlson, S. (1994) Dissociation of the alpha 2-adrenergic antinociception from sedation following microinjection of medetomidine into the locus coeruleus in rats. Pain, 57, 207-215.
67. Rainger, J., Baxter, C., Vogelnest, L. & Dart, C. (2009) Seizures during medetomindine sedation and local anaesthesia in two dogs undergoing skin biopsy. Aust. Vet. J., 87, 188-192.
68. Ramos-Cabrer, P., Weber, R., Wiedermann, D. & Hoehn, M. (2005) Continuous noninvasive monitoring of transcutaneous blood gases for a stable and persistent BOLD contrast in fMRI studies in the rat. NMR Biomed., 18, 440-446.
69. Reid, K., Hayashi, Y., Guo, T.Z., Correa-Sales, C., Nacif-Coelho, C. & Maze, M. (1994) Chronic administration of an alpha 2 adrenergic agonist desensitizes rats to the anesthetic effects of dexmedetomidine. Pharmacol. Biochem. Behav., 47, 171-175.
70. Samuels, E.R. & Szabadi, E. (2008) Functional neuroanatomy of the noradrenergic locus coeruleus: its roles in the regulation of arousal and autonomic function part II: physiological and pharmacological manipulations and pathological alterations of locus coeruleus activity in humans. Curr. Neuropharmacol., 6, 254-285.
71. Savola, J.M. & Virtanen, R. (1991) Central alpha 2-adrenoceptors are highly stereoselective for dexmedetomidine, the dextro enantiomer of medetomidine. Eur. J. Pharmacol., 195, 193-199.
72. Savola, M.K., MacIver, M.B., Doze, V.A., Kendig, J.J. & Maze, M. (1991) The alpha 2-adrenoceptor agonist dexmedetomidine increases the apparent potency of the volatile anesthetic isoflurane in rats in vivo and in hippocampal slice in vitro. Brain Res., 548, 23-28.
73. Scheinin, H., Virtanen, R., MacDonald, E., Lammintausta, R. & Scheinin, M. (1989) Medetomidine - a novel alpha 2-adrenoceptor agonist: a review of its pharmacodynamic effects. Prog. Neuropsychopharmacol. Biol. Psychiatry, 13, 635-651.
74. Schmeling, W.T., Kampine, J.P., Roerig, D.L. & Warltier, D.C. (1991) The effects of the stereoisomers of the alpha 2-adrenergic agonist medetomidine on systemic and coronary hemodynamics in conscious dogs. Anesthesiology, 75, 499-511.
75. Schwechter, E.M., Veliskova, J. & Velisek, L. (2003) Correlation between extracellular glucose and seizure susceptibility in adult rats. Ann. Neurol., 53, 91-101.
76. Schwinn, D.A., Correa-Sales, C., Page, S.O. & Maze, M. (1991) Functional effects of activation of alpha-1 adrenoceptors by dexmedetomidine: in vivo and in vitro studies. J. Pharmacol. Exp. Ther., 259, 1147-1152.
77. Seehafer, J.U., Kalthoff, D., Farr, T.D., Wiedermann, D. & Hoehn, M. (2010) No increase of the blood oxygenation level-dependent functional magnetic resonance imaging signal with higher field strength: implications for brain activation studies. J. Neurosci., 30, 5234-5241.
78. Segal, I.S., Vickery, R.G., Walton, J.K., Doze, V.A. & Maze, M. (1988) Dexmedetomidine diminishes halothane anesthetic requirements in rats through a postsynaptic alpha 2 adrenergic receptor. Anesthesiology, 69, 818-823.
79. Sinclair, M.D. (2003) A review of the physiological effects of alpha2-agonists related to the clinical use of medetomidine in small animal practice. Can. Vet. J., 44, 885-897.
80. Sloan, T., Sloan, H. & Rogers, J. (2010) Nitrous oxide and isoflurane are synergistic with respect to amplitude and latency effects on sensory evoked potentials. J. Clin. Monit. Comput., 24, 113-123.
81. Sloan, T.B. (1998) Anesthetic effects on electrophysiologic recordings. J. Clin. Neurophysiol., 15, 217-226.
82. Takano, T., Tian, G.F., Peng, W., Lou, N., Libionka, W., Han, X. & Nedergaard, M. (2006) Astrocyte-mediated control of cerebral blood flow. Nat. Neurosci., 9, 260-267.
83. Talley, E.M., Rosin, D.L., Lee, A., Guyenet, P.G. & Lynch, K.R. (1996) Distribution of alpha 2A-adrenergic receptor-like immunoreactivity in the rat central nervous system. J. Comp. Neurol., 372, 111-134.
84. Van Camp, N., Verhoye, M., De Zeeuw, C.I. & Van der Linden, A. (2006) Light stimulus frequency dependence of activity in the rat visual system as studied with high-resolution BOLD fMRI. J. Neurophysiol., 95, 3164-3170.
85. Vaucher, E. & Hamel, E. (1995) Cholinergic basal forebrain neurons project to cortical microvessels in the rat: electron microscopic study with anterogradely transported Phaseolus vulgaris leucoagglutinin and choline acetyltransferase immunocytochemistry. J. Neurosci., 15, 7427-7441.
86. Vazquez, A.L., Fukuda, M., Tasker, M.L., Masamoto, K. & Kim, S.G. (2010a) Changes in cerebral arterial, tissue and venous oxygenation with evoked neural stimulation: implications for hemoglobin-based functional neuroimaging. J. Cereb. Blood Flow Metab., 30, 428-439.
87. Vazquez, A.L., Masamoto, K., Fukuda, M. & Kim, S.G. (2010b) Cerebral oxygen delivery and consumption during evoked neural activity. Front. Neuroenergetics, 2, 11.
88. Vazquez, A.L., Fukuda, M. & Kim, S.G. (2012) Evolution of the dynamic changes in functional cerebral oxidative metabolism from tissue mitochondria to blood oxygen. J. Cereb. Blood Flow Metab., 32, 745-758.
89. Vickery, R.G. & Maze, M. (1989) Action of the stereoisomers of medetomidine, in halothane-anesthetized dogs. Acta Vet. Scand. Suppl., 85, 71-76.
90. Weber, R., Ramos-Cabrer, P., Wiedermann, D., van Camp, N. & Hoehn, M. (2006) A fully noninvasive and robust experimental protocol for longitudinal fMRI studies in the rat. Neuroimage, 29, 1303-1310.
91. Weber, R., Ramos-Cabrer, P., Justicia, C., Wiedermann, D., Strecker, C., Sprenger, C. & Hoehn, M. (2008) Early prediction of functional recovery after experimental stroke: functional magnetic resonance imaging, electrophysiology, and behavioral testing in rats. J. Neurosci., 28, 1022-1029.
92. White, P.F., Johnston, R.R. & Eger, E.I. 2nd (1974) Determination of anesthetic requirement in rats. Anesthesiology, 40, 52-57.
93. Williams, K.A., Magnuson, M., Majeed, W., LaConte, S.M., Peltier, S.J., Hu, X. & Keilholz, S.D. (2010) Comparison of alpha-chloralose, medetomidine and isoflurane anesthesia for functional connectivity mapping in the rat. Magn. Reson. Imaging, 28, 995-1003.
94. Zhang, Y., Eger, E.I. 2nd, Dutton, R.C. & Sonner, J.M. (2000) Inhaled anesthetics have hyperalgesic effects at 0.1 minimum alveolar anesthetic concentration. Anesth. Analg., 91, 462-466.
95. Zhao, F., Zhao, T., Zhou, L., Wu, Q. & Hu, X. (2008) BOLD study of stimulation-induced neural activity and resting-state connectivity in medetomidine-sedated rat. Neuroimage, 39, 248-260.
96. Zhao, F., Welsh, D., Williams, M., Coimbra, A., Urban, M.O., Hargreaves, R., Evelhoch, J. & Williams, D.S. (2012) fMRI of pain processing in the brain: a within-animal comparative study of BOLD vs. CBV and noxious electrical vs. noxious mechanical stimulation in rat. Neuroimage, 59, 1168-1179.
97. Zong, X., Kim, T. & Kim, S.G. (2012) Contributions of dynamic venous blood volume versus oxygenation level changes to BOLD fMRI. Neuroimage, 60, 2238-2246.
98. Zonta, M., Angulo, M.C., Gobbo, S., Rosengarten, B., Hossmann, K.A., Pozzan, T. & Carmignoto, G. (2003) Neuron-to-astrocyte signaling is central to the dynamic control of brain microcirculation. Nat. Neurosci., 6, 43-50.
99. Zornow, M.H., Fleischer, J.E., Scheller, M.S., Nakakimura, K. & Drummond, J.C. (1990) Dexmedetomidine, an alpha 2-adrenergic agonist, decreases cerebral blood flow in the isoflurane-anesthetized dog. Anesth. Analg., 70, 624-630.